+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Genetic Technologies Ltd (GTG) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 51 Pages
  • October 2023
  • GlobalData
  • ID: 1322535
Genetic Technologies Ltd (GTG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company's operations and business divisions.
  • Corporate strategy - Analyst's summarization of the company's business strategy.
  • SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives' employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Genetic Technologies Ltd (GTG) is a molecular diagnostic company that offers testing products and services to assess sporadic breast cancer risk and colorectal cancer risk assessment. The company delivers the offerings by GeneType for breast cancer tests and GeneType test for colorectal cancer. GeneType for breast cancer, a test that examines woman's clinical risk factors with scientifically validated genetic biomarkers, to enable personalized breast cancer risk assessment and GeneType for Colorectal Cancer combines patient age, genetic markers and family history to provide more accurate assessment of colorectal cancer risk. The company serves healthcare providers and patients in the US and Australia. GTG is headquartered in Fitzroy, Victoria, Australia.

Genetic Technologies Ltd Key Recent Developments

  • Jul 28, 2023: Quarterly Activities Update: Encouraging Growth for Genetype Commercial Test Volume
  • Apr 28, 2023: New publication validates geneType for melanoma risk assessment
  • Feb 17, 2023: Genetic Technologies : Receipt of R&D tax incentive refund for geneType multi test
  • Feb 01, 2023: GTG to form strategic alliance with global testing leader QIAGEN

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Genetic Technologies Ltd - Key Facts
  • Genetic Technologies Ltd - Key Employees
  • Genetic Technologies Ltd - Key Employee Biographies
  • Genetic Technologies Ltd - Major Products and Services
  • Genetic Technologies Ltd - History
  • Genetic Technologies Ltd - Company Statement
  • Genetic Technologies Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Genetic Technologies Ltd - Business Description
  • Business Segment: AffinityDNA
  • Performance
  • Business Segment: EasyDNA
  • Performance
  • Business Segment: GeneType/ Corporate
  • Performance
  • Geographical Segment: America and Canada
  • Performance
  • Geographical Segment: Asia Pacific
  • Performance
  • Geographical Segment: Europe Middle East and Africa
  • Performance
  • Geographical Segment: Latin America
  • Performance
  • R&D Overview
  • Genetic Technologies Ltd - Corporate Strategy
  • Genetic Technologies Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Genetic Technologies Ltd - Strengths
  • Genetic Technologies Ltd - Weaknesses
  • Genetic Technologies Ltd - Opportunities
  • Genetic Technologies Ltd - Threats
  • Genetic Technologies Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Genetic Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Genetic Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Genetic Technologies Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jul 28, 2023: Quarterly Activities Update: Encouraging Growth for Genetype Commercial Test Volume
  • Apr 28, 2023: New publication validates geneType for melanoma risk assessment
  • Feb 17, 2023: Genetic Technologies : Receipt of R&D tax incentive refund for geneType multi test
  • Feb 01, 2023: GTG to form strategic alliance with global testing leader QIAGEN
  • Jan 24, 2023: Genetic Technologies presented improved clinical colorectal cancer risk prediction model integrating polygenic risk at ASCOGI Cancer Symposium
  • Jan 24, 2023: Improved Clinical Colorectal Cancer Risk Prediction Model Integrating Polygenic Risk Presented at ASCOGI Cancer Symposium
  • Jan 11, 2023: Genetic Technologies provides business update
  • Oct 10, 2022: Genetic Technologies : Appointment of CFO and Company Secretary
  • Sep 29, 2022: Journal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for breast cancer
  • Sep 02, 2022: Genetic Technologies provides update on US Operations and Payer Engagement
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Analyst
  • Disclaimer
List of Tables
  • Genetic Technologies Ltd, Key Facts
  • Genetic Technologies Ltd, Key Employees
  • Genetic Technologies Ltd, Key Employee Biographies
  • Genetic Technologies Ltd, Major Products and Services
  • Genetic Technologies Ltd, History
  • Genetic Technologies Ltd, Subsidiaries
  • Genetic Technologies Ltd, Key Competitors
  • Genetic Technologies Ltd, Ratios based on current share price
  • Genetic Technologies Ltd, Annual Ratios
  • Genetic Technologies Ltd, Annual Ratios (Cont...1)
  • Genetic Technologies Ltd, Interim Ratios
  • Genetic Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Genetic Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Genetic Technologies Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Genetic Technologies Ltd, Performance Chart (2019 - 2023)
  • Genetic Technologies Ltd, Ratio Charts
  • Genetic Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Genetic Technologies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Universal Biosensors Pty Ltd.
  • Sonic Healthcare Ltd
  • Portland Surgical Products Pty Ltd
  • Pharmaxis Ltd
  • AusBiotech Ltd